Akiko Kojima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akiko Kojima has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Hirotoshi Kitagawa
Department of Anesthesiology, Shiga University of Medical Science
12 shared publications- Hiroshi Matsuura
Shiga University of Medical Science
10 shared publications Hiroshi Matsuura
Department of Physiology, Shiga University of Medical Science, Otsu, Japan
7 shared publicationsYuki Ito
Anesthesiology; and
6 shared publicationsYutaka Fukushima
Department of Anesthesiology, Shiga University of Medical Science, Otsu, Japan
6 shared publications- Mariko Omatsu-Kanbe
Department of Physiology, Shiga University of Medical Science
5 shared publications
Latest Publications
- Open Access
- 30 January 2024
- Published by Wiley
Selective activation of adrenoceptors potentiates I Ks current in pulmonary vein cardiomyocytes through the protein kinase A and C signaling pathways
BACKGROUND AND PURPOSE Delayed rectifier K + current ( I Ks ) is a key contributor to repolarization of action potentials. This study investigated the mechanisms underlying the adrenoceptor-induced potentiation of I Ks in pulmonary vein cardiomyocytes (PVC). EXPERIMENTAL APPROACH PVC were isolated from guinea pig pulmonary vein. The action potentials and I Ks current were recorded using perforated and conventional whole-cell patch-clamp techniques. The expression of I Ks was examined using immunocytochemistry and Western blotting. KEY RESULTS The I Ks current in PVC was markedly enhanced by both β 1 - and β 2 -adrenoceptor stimulation with negative voltage shift in the current activation, although the potentiation was more effectively induced by β 2 -adrenoceptor stimulation than β 1 -adrenoceptor stimulation. Both β-adrenoceptor-mediated increases in I Ks were attenuated by treatment with the adenylyl cyclase (AC) inhibitor or protein kinase A (PKA) inhibitor. Furthermore, the I Ks current was increased by α 1 -adrenoceptor agonist but attenuated by the protein kinase C (PKC) inhibitor. PVC exhibited action potentials in normal Tyrode solution which was slightly reduced by HMR-1556 a selective I Ks blocker. However, HMR-1556 markedly reduced the β-adrenoceptor-potentiated firing rate. KCNQ1 , a I Ks pore-forming protein was detected as a signal band approximately 65 kDa in size, and its immunofluorescence signal was found to be mainly localized on the cell membrane. CONCLUSIONS AND IMPLICATIONS The stimulatory effects of β- and α 1 -adrenoceptor on I Ks in PVC are mediated via the PKA and PKC signal pathways. HMR-1556 effectively reduced the firing rate under β-adrenoceptor activation, suggesting that the functional role of I Ks might increase during sympathetic excitation under in vivo conditions.
- 30 January 2024
- Published by Wiley
Open AccessSelective activation of adrenoceptors potentiates I Ks current in pulmonary vein cardiomyocytes through the protein kinase A and C signaling pathways
BACKGROUND AND PURPOSE Delayed rectifier K + current ( I Ks ) is a key contributor to repolarization of action potentials. This study investigated the mechanisms underlying the adrenoceptor-induced potentiation of I Ks in pulmonary vein cardiomyocytes (PVC). EXPERIMENTAL APPROACH PVC were isolated from guinea pig pulmonary vein. The action potentials and I Ks current were recorded using perforated and conventional whole-cell patch-clamp techniques. The expression of I Ks was examined using immunocytochemistry and Western blotting. KEY RESULTS The I Ks current in PVC was markedly enhanced by both β 1 - and β 2 -adrenoceptor stimulation with negative voltage shift in the current activation, although the potentiation was more effectively induced by β 2 -adrenoceptor stimulation than β 1 -adrenoceptor stimulation. Both β-adrenoceptor-mediated increases in I Ks were attenuated by treatment with the adenylyl cyclase (AC) inhibitor or protein kinase A (PKA) inhibitor. Furthermore, the I Ks current was increased by α 1 -adrenoceptor agonist but attenuated by the protein kinase C (PKC) inhibitor. PVC exhibited action potentials in normal Tyrode solution which was slightly reduced by HMR-1556 a selective I Ks blocker. However, HMR-1556 markedly reduced the β-adrenoceptor-potentiated firing rate. KCNQ1 , a I Ks pore-forming protein was detected as a signal band approximately 65 kDa in size, and its immunofluorescence signal was found to be mainly localized on the cell membrane. CONCLUSIONS AND IMPLICATIONS The stimulatory effects of β- and α 1 -adrenoceptor on I Ks in PVC are mediated via the PKA and PKC signal pathways. HMR-1556 effectively reduced the firing rate under β-adrenoceptor activation, suggesting that the functional role of I Ks might increase during sympathetic excitation under in vivo conditions.
- 31 July 2023
- Published by Springer Nature in Journal of Anesthesia
- Vol. 37 (5) , 806-810
Prediction of anesthetic torsadogenicity using a human ventricular cell model
This simulation study was designed to predict the torsadogenicity of sevoflurane and propofol in healthy control, as well as type 1 and type 2 long QT syndrome (LQT1 and LQT2, respectively), using the O'Hara-Rudy dynamic model. LQT1 and LQT2 models were simulated by decreasing the conductances of slowly and rapidly activating delayed rectifier K+ currents (IKs and IKr, respectively) by 50%, respectively. Action potential duration at 50% repolarization level (APD50) and diastolic intracellular Ca2+ concentration were measured in epicardial cell during administration of sevoflurane (1 ~ 5%) and propofol (1 ~ 10 μM). Torsadogenicity can be predicted from the relationship between APD50 and diastolic intracellular Ca2+ concentration, which is classified by the decision boundary. Whereas the relationships in control and LQT1 models were distributed on nontorsadogenic side in the presence of sevoflurane at all tested concentrations, those in LQT2 models were shifted to torsadogenic side by concentrations of ≥ 2%. In all three models, propofol shifted the relationships in a direction away from the decision boundary on nontorsadogenic side. Our findings suggest that sevoflurane, but not propofol, exerts torsadogenicity in patients with reduced IKr, such as LQT2 patients. Caution should be paid to the occurrence of arrhythmia during sevoflurane anesthesia in patients with reduced IKr.
- 31 July 2023
- Published by Springer Nature in Journal of Anesthesia
- Vol. 37 (5) , 806-810
Prediction of anesthetic torsadogenicity using a human ventricular cell model
This simulation study was designed to predict the torsadogenicity of sevoflurane and propofol in healthy control, as well as type 1 and type 2 long QT syndrome (LQT1 and LQT2, respectively), using the O'Hara-Rudy dynamic model. LQT1 and LQT2 models were simulated by decreasing the conductances of slowly and rapidly activating delayed rectifier K+ currents (IKs and IKr, respectively) by 50%, respectively. Action potential duration at 50% repolarization level (APD50) and diastolic intracellular Ca2+ concentration were measured in epicardial cell during administration of sevoflurane (1 ~ 5%) and propofol (1 ~ 10 μM). Torsadogenicity can be predicted from the relationship between APD50 and diastolic intracellular Ca2+ concentration, which is classified by the decision boundary. Whereas the relationships in control and LQT1 models were distributed on nontorsadogenic side in the presence of sevoflurane at all tested concentrations, those in LQT2 models were shifted to torsadogenic side by concentrations of ≥ 2%. In all three models, propofol shifted the relationships in a direction away from the decision boundary on nontorsadogenic side. Our findings suggest that sevoflurane, but not propofol, exerts torsadogenicity in patients with reduced IKr, such as LQT2 patients. Caution should be paid to the occurrence of arrhythmia during sevoflurane anesthesia in patients with reduced IKr.
- Open Access
- 15 July 2022
- Published by Japan Society for Clinical Anesthesia in THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
- Vol. 42 (4) , 335-339
A Case of Intubation Using Airway Scope Instead of Fiberoptic Bronchoscope for a Patient with a Laryngeal Tumor on the Vocal Fold
喉頭腫瘍などの上気道占拠性病変を有する症例では,全身麻酔導入のどの段階においても,マスク換気困難,挿管困難に陥る可能性がある.腫瘍により声門へのアプローチが困難になるだけでなく,気管チューブ挿入時の接触により腫瘍の嵌頓や損傷,出血などをきたし,気道閉塞を引き起こすリスクがある.今回,声門直上の喉頭肉芽腫を有する患者の気道確保に病変部である声門の通過が盲目的となる気管支ファイバースコープよりもエアウェイスコープの使用が適切であった症例を経験した.このような症例では,ビデオ喉頭鏡などを用いての腫瘍と気管チューブとの接触の回避を含む確実な気道確保戦略を講じることが重要である.
- 15 July 2022
- Published by Japan Society for Clinical Anesthesia in THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
- Vol. 42 (4) , 335-339
Open AccessA Case of Intubation Using Airway Scope Instead of Fiberoptic Bronchoscope for a Patient with a Laryngeal Tumor on the Vocal Fold
喉頭腫瘍などの上気道占拠性病変を有する症例では,全身麻酔導入のどの段階においても,マスク換気困難,挿管困難に陥る可能性がある.腫瘍により声門へのアプローチが困難になるだけでなく,気管チューブ挿入時の接触により腫瘍の嵌頓や損傷,出血などをきたし,気道閉塞を引き起こすリスクがある.今回,声門直上の喉頭肉芽腫を有する患者の気道確保に病変部である声門の通過が盲目的となる気管支ファイバースコープよりもエアウェイスコープの使用が適切であった症例を経験した.このような症例では,ビデオ喉頭鏡などを用いての腫瘍と気管チューブとの接触の回避を含む確実な気道確保戦略を講じることが重要である.
- Open Access
- 12 April 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (4) , 570
Propofol, an Anesthetic Agent, Inhibits HCN Channels through the Allosteric Modulation of the cAMP-Dependent Gating Mechanism
Propofol is a broadly used intravenous anesthetic agent that can cause cardiovascular effects, including bradycardia and asystole. A possible mechanism for these effects is slowing cardiac pacemaker activity due to inhibition of the hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels. However, it remains unclear how propofol affects the allosteric nature of the voltage- and cAMP-dependent gating mechanism in HCN channels. To address this aim, we investigated the effect of propofol on HCN channels (HCN4 and HCN2) in heterologous expression systems using a whole-cell patch clamp technique. The extracellular application of propofol substantially suppressed the maximum current at clinical concentrations. This was accompanied by a hyperpolarizing shift in the voltage dependence of channel opening. These effects were significantly attenuated by intracellular loading of cAMP, even after considering the current modification by cAMP in opposite directions. The differential degree of propofol effects in the presence and absence of cAMP was rationalized by an allosteric gating model for HCN channels, where we assumed that propofol affects allosteric couplings between the pore, voltage-sensor, and cyclic nucleotide-binding domain (CNBD). The model predicted that propofol enhanced autoinhibition of pore opening by unliganded CNBD, which was relieved by the activation of CNBD by cAMP. Taken together, these findings reveal that propofol acts as an allosteric modulator of cAMP-dependent gating in HCN channels, which may help us to better understand the clinical action of this anesthetic drug.
- 12 April 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (4) , 570
Open AccessPropofol, an Anesthetic Agent, Inhibits HCN Channels through the Allosteric Modulation of the cAMP-Dependent Gating Mechanism
Propofol is a broadly used intravenous anesthetic agent that can cause cardiovascular effects, including bradycardia and asystole. A possible mechanism for these effects is slowing cardiac pacemaker activity due to inhibition of the hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels. However, it remains unclear how propofol affects the allosteric nature of the voltage- and cAMP-dependent gating mechanism in HCN channels. To address this aim, we investigated the effect of propofol on HCN channels (HCN4 and HCN2) in heterologous expression systems using a whole-cell patch clamp technique. The extracellular application of propofol substantially suppressed the maximum current at clinical concentrations. This was accompanied by a hyperpolarizing shift in the voltage dependence of channel opening. These effects were significantly attenuated by intracellular loading of cAMP, even after considering the current modification by cAMP in opposite directions. The differential degree of propofol effects in the presence and absence of cAMP was rationalized by an allosteric gating model for HCN channels, where we assumed that propofol affects allosteric couplings between the pore, voltage-sensor, and cyclic nucleotide-binding domain (CNBD). The model predicted that propofol enhanced autoinhibition of pore opening by unliganded CNBD, which was relieved by the activation of CNBD by cAMP. Taken together, these findings reveal that propofol acts as an allosteric modulator of cAMP-dependent gating in HCN channels, which may help us to better understand the clinical action of this anesthetic drug.
- 24 March 2021
- Published by Wiley in British Journal of Pharmacology
- Vol. 178 (13) , 2690-2708
Elevation of propofol sensitivity of cardiac IKs channel by KCNE1 polymorphism D85N
Background and Purpose The slowly activating delayed rectifier K+ channel (IKs), composed of pore‐forming KCNQ1 α‐subunits and ancillary KCNE1 β‐subunits, regulates ventricular repolarization in human heart. Propofol at clinically used concentrations modestly inhibits the intact (wild‐type) IKs channels and is therefore unlikely to appreciably prolong QT interval in electrocardiogram during anesthesia. However, little information is available concerning the inhibitory effect of propofol on IKs channel associated with its gene variants implicated in QT prolongation. The KCNE1 single nucleotide polymorphism leading to D85N is associated with drug‐induced QT prolongation and therefore regarded as a clinically important genetic variant. This study examined whether KCNE1‐D85N affects the sensitivity of IKs to inhibition by propofol. Experimental Approach Whole‐cell patch‐clamp and immunostaining experiments were conducted in human embryonic kidney 293 (HEK293) cells and/or mouse cardiomyocyte‐derived HL‐1 cells, transfected with wild‐type KCNQ1, wild‐type or variant KCNE1 cDNAs. Key Results Propofol inhibited KCNQ1/KCNE1‐D85N current more potently than KCNQ1/KCNE1 current in HEK293 cells and HL‐1 cells. Immunostaining experiments in HEK293 cells revealed that pretreatment with propofol (10 μM) did not appreciably affect cell membrane expression of KCNQ1 and KCNE1 proteins in KCNQ1/KCNE1 and KCNQ1/KCNE1‐D85N channels. Conclusion and Implications The KCNE1 polymorphism D85N significantly elevates the sensitivity of IKs to inhibition by propofol. This study detects a functionally important role of KCNE1‐D85N polymorphism in conferring genetic susceptibility to propofol‐induced QT prolongation and further suggests the possibility that the inhibitory action of anesthetics on ionic currents becomes exaggerated in patients carrying variants in genes encoding ion channels.
- 24 March 2021
- Published by Wiley in British Journal of Pharmacology
- Vol. 178 (13) , 2690-2708
Elevation of propofol sensitivity of cardiac IKs channel by KCNE1 polymorphism D85N
Background and Purpose The slowly activating delayed rectifier K+ channel (IKs), composed of pore‐forming KCNQ1 α‐subunits and ancillary KCNE1 β‐subunits, regulates ventricular repolarization in human heart. Propofol at clinically used concentrations modestly inhibits the intact (wild‐type) IKs channels and is therefore unlikely to appreciably prolong QT interval in electrocardiogram during anesthesia. However, little information is available concerning the inhibitory effect of propofol on IKs channel associated with its gene variants implicated in QT prolongation. The KCNE1 single nucleotide polymorphism leading to D85N is associated with drug‐induced QT prolongation and therefore regarded as a clinically important genetic variant. This study examined whether KCNE1‐D85N affects the sensitivity of IKs to inhibition by propofol. Experimental Approach Whole‐cell patch‐clamp and immunostaining experiments were conducted in human embryonic kidney 293 (HEK293) cells and/or mouse cardiomyocyte‐derived HL‐1 cells, transfected with wild‐type KCNQ1, wild‐type or variant KCNE1 cDNAs. Key Results Propofol inhibited KCNQ1/KCNE1‐D85N current more potently than KCNQ1/KCNE1 current in HEK293 cells and HL‐1 cells. Immunostaining experiments in HEK293 cells revealed that pretreatment with propofol (10 μM) did not appreciably affect cell membrane expression of KCNQ1 and KCNE1 proteins in KCNQ1/KCNE1 and KCNQ1/KCNE1‐D85N channels. Conclusion and Implications The KCNE1 polymorphism D85N significantly elevates the sensitivity of IKs to inhibition by propofol. This study detects a functionally important role of KCNE1‐D85N polymorphism in conferring genetic susceptibility to propofol‐induced QT prolongation and further suggests the possibility that the inhibitory action of anesthetics on ionic currents becomes exaggerated in patients carrying variants in genes encoding ion channels.
- 20 May 2020
- Published by Wiley in British Journal of Pharmacology
- Vol. 177 (16) , 3811-3827
Open‐channel blocking action of volatile anaesthetics desflurane and sevoflurane on human voltage‐gated Kv1.5 channel
Background and Purpose: Volatile anaesthetics have been shown to differentially modulate mammalian Shaker‐related voltage‐gated potassium (Kv1.x) channels. This study was designed to investigate molecular and cellular mechanisms underlying the modulatory effects of desflurane or sevoflurane on human Kv1.5 (hKv1.5) channels.Experimental Approach: Thirteen single‐point mutations were constructed within pore domain of hKv1.5 channel using site‐directed mutagenesis. The effects of desflurane or sevoflurane on heterologously expressed wild‐type and mutant hKv1.5 channels were examined by whole‐cell patch‐clamp technique. A computer simulation was conducted to predict the docking pose of desflurane or sevoflurane within hKv1.5 channel.Key Results: Both desflurane and sevoflurane increased hKv1.5 current at mild depolarizations but decreased it at strong depolarizations, indicating that these anaesthetics produce both stimulatory and inhibitory actions on hKv1.5 channels. The inhibitory effect of desflurane or sevoflurane on hKv1.5 channels arose primarily from its open‐channel blocking action. The inhibitory action of desflurane or sevoflurane on hKv1.5 channels was significantly attenuated in T480A, V505A, and I508A mutant channels, compared with wild‐type channel. Computational docking simulation predicted that desflurane or sevoflurane resides within the inner cavity of channel pore and has contact with Thr479, Thr480, Val505, and Ile508.Conclusion and Implications: Desflurane and sevoflurane exert an open‐channel blocking action on hKv1.5 channels by functionally interacting with specific amino acids located within the channel pore. This study thus identifies a novel molecular basis mediating inhibitory modulation of hKv1.5 channels by desflurane and sevoflurane.
- 20 May 2020
- Published by Wiley in British Journal of Pharmacology
- Vol. 177 (16) , 3811-3827
Open‐channel blocking action of volatile anaesthetics desflurane and sevoflurane on human voltage‐gated Kv1.5 channel
Background and Purpose: Volatile anaesthetics have been shown to differentially modulate mammalian Shaker‐related voltage‐gated potassium (Kv1.x) channels. This study was designed to investigate molecular and cellular mechanisms underlying the modulatory effects of desflurane or sevoflurane on human Kv1.5 (hKv1.5) channels.Experimental Approach: Thirteen single‐point mutations were constructed within pore domain of hKv1.5 channel using site‐directed mutagenesis. The effects of desflurane or sevoflurane on heterologously expressed wild‐type and mutant hKv1.5 channels were examined by whole‐cell patch‐clamp technique. A computer simulation was conducted to predict the docking pose of desflurane or sevoflurane within hKv1.5 channel.Key Results: Both desflurane and sevoflurane increased hKv1.5 current at mild depolarizations but decreased it at strong depolarizations, indicating that these anaesthetics produce both stimulatory and inhibitory actions on hKv1.5 channels. The inhibitory effect of desflurane or sevoflurane on hKv1.5 channels arose primarily from its open‐channel blocking action. The inhibitory action of desflurane or sevoflurane on hKv1.5 channels was significantly attenuated in T480A, V505A, and I508A mutant channels, compared with wild‐type channel. Computational docking simulation predicted that desflurane or sevoflurane resides within the inner cavity of channel pore and has contact with Thr479, Thr480, Val505, and Ile508.Conclusion and Implications: Desflurane and sevoflurane exert an open‐channel blocking action on hKv1.5 channels by functionally interacting with specific amino acids located within the channel pore. This study thus identifies a novel molecular basis mediating inhibitory modulation of hKv1.5 channels by desflurane and sevoflurane.
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 71 (4) , 248-255
Transient Receptor Potential Canonical Channel Blockers Improve Ventricular Contractile Functions After Ischemia/Reperfusion in a Langendorff-perfused Mouse Heart Model
Reperfusion of ischemic myocardium is accompanied by intracellular Ca2+ overload, leading to cardiac dysfunction. However, the mechanisms underlying intracellular Ca2+ overload have yet to be fully elucidated. The mechanism may involve the activation of store-operated Ca2+ entry, which is primarily mediated through the transient receptor potential canonical (TRPC) channels. This study was undertaken to examine the possible involvement of TRPC channels in the development of contractile dysfunction associated with reperfusion of ischemic myocardium using a mouse heart model. The functional expression of TRPC channels was confirmed in mouse ventricular myocytes using immunocytochemistry, Western blotting, and patch-clamp experiments. The left ventricular functions were assessed by measuring left ventricular end-diastolic pressure, left ventricular developed pressure, and its first derivatives in a Langendorff-perfused mouse heart subjected to 30 minutes of normothermic (37°C) global ischemia followed by 60 minutes of reperfusion. Under control conditions, left ventricular functions were deteriorated during reperfusion, which was significantly ameliorated by administration of the TRPC channel blockers 2-aminoethoxydiphenyl borate and La3+ during initial 5 minutes of reperfusion. Our findings suggest that TRPC channels are involved in mediating contractile dysfunction during reperfusion of ischemic myocardium and detect TRPC channels as a potential therapeutic target for preventing myocardial ischemia/reperfusion injury.
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 71 (4) , 248-255
Transient Receptor Potential Canonical Channel Blockers Improve Ventricular Contractile Functions After Ischemia/Reperfusion in a Langendorff-perfused Mouse Heart Model
Reperfusion of ischemic myocardium is accompanied by intracellular Ca2+ overload, leading to cardiac dysfunction. However, the mechanisms underlying intracellular Ca2+ overload have yet to be fully elucidated. The mechanism may involve the activation of store-operated Ca2+ entry, which is primarily mediated through the transient receptor potential canonical (TRPC) channels. This study was undertaken to examine the possible involvement of TRPC channels in the development of contractile dysfunction associated with reperfusion of ischemic myocardium using a mouse heart model. The functional expression of TRPC channels was confirmed in mouse ventricular myocytes using immunocytochemistry, Western blotting, and patch-clamp experiments. The left ventricular functions were assessed by measuring left ventricular end-diastolic pressure, left ventricular developed pressure, and its first derivatives in a Langendorff-perfused mouse heart subjected to 30 minutes of normothermic (37°C) global ischemia followed by 60 minutes of reperfusion. Under control conditions, left ventricular functions were deteriorated during reperfusion, which was significantly ameliorated by administration of the TRPC channel blockers 2-aminoethoxydiphenyl borate and La3+ during initial 5 minutes of reperfusion. Our findings suggest that TRPC channels are involved in mediating contractile dysfunction during reperfusion of ischemic myocardium and detect TRPC channels as a potential therapeutic target for preventing myocardial ischemia/reperfusion injury.
- 1 January 2018
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 71 (1) , 10-18
Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses
Propofol blocks the voltage-gated human Kv1.5 (hKv1.5) channel by preferentially affecting in its open state. A previous mutational study suggested that several amino acids within the pore region of the hKv1.5 channel are involved in mediating the blocking action of propofol. The present investigation was undertaken to elucidate the predicted binding modes of propofol within the pore cavity of the open-state hKv1.5 channel, using computational docking and mutagenesis approaches. The docking simulation using a homology model of the hKv1.5 channel, constructed based on the crystal structure of the Kv1.2 channel, predicted that propofol was positioned at the base of the pore cavity of hKv1.5 channel, adjacent to 4 amino acids Thr479, Thr480, Val505, and Ile508, and formed arene-H interactions with Val505. The patch-clamp experiments on wild-type and mutant hKv1.5 channels constructed by site-directed mutagenesis revealed that the blocking potency of propofol was significantly reduced in T480A, V505A, and I508A but not in T479A mutants compared with wild-type hKv1.5 channel. These computational docking and experimental mutational analyses suggest that propofol is positioned at the base of the pore cavity and forms functional contact with Thr480, Val505, and Ile508 to directly block the hKv1.5 channel.
- 1 January 2018
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 71 (1) , 10-18
Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses
Propofol blocks the voltage-gated human Kv1.5 (hKv1.5) channel by preferentially affecting in its open state. A previous mutational study suggested that several amino acids within the pore region of the hKv1.5 channel are involved in mediating the blocking action of propofol. The present investigation was undertaken to elucidate the predicted binding modes of propofol within the pore cavity of the open-state hKv1.5 channel, using computational docking and mutagenesis approaches. The docking simulation using a homology model of the hKv1.5 channel, constructed based on the crystal structure of the Kv1.2 channel, predicted that propofol was positioned at the base of the pore cavity of hKv1.5 channel, adjacent to 4 amino acids Thr479, Thr480, Val505, and Ile508, and formed arene-H interactions with Val505. The patch-clamp experiments on wild-type and mutant hKv1.5 channels constructed by site-directed mutagenesis revealed that the blocking potency of propofol was significantly reduced in T480A, V505A, and I508A but not in T479A mutants compared with wild-type hKv1.5 channel. These computational docking and experimental mutational analyses suggest that propofol is positioned at the base of the pore cavity and forms functional contact with Thr480, Val505, and Ile508 to directly block the hKv1.5 channel.